Navigation Links
Vantia Therapeutics' Pipeline Continues to Mature
Date:3/24/2009

SOUTHAMPTON, England, March 24 /PRNewswire/ --

- VA106483 Completes Phase IIa Trial and VA111913 Completes Phase I Dosing

Vantia Therapeutics, a company focusing on first-in-class therapies for unmet medical needs, announces further clinical trial progress with its two lead development compounds, VA106483 for nocturia associated with benign prostatic hypertrophy (BPH) and VA111913 for dysmenorrhoea. The Phase IIa trial of VA106483 has completed, while dosing is complete in the Phase I trial of VA111913. With this news and developments in Vantia's preclinical pipeline, the company is continuing to generate value from its extensive library of small molecule antagonists of hormones and proteases.

Following the completion of the 27-patient Phase IIa trial of VA106483, a vasopressin agonist, results are expected in H1 2009, with the Phase IIb study expected to start in the second half of the year. Up to 200 males with nocturia are expected to be involved in this dose-finding placebo-controlled study, which is expected to complete in the first half of 2010.

Given Vantia Therapeutics' strategy of developing products to the end of proof of concept/Phase IIb trials, the product is expected to be outlicensed for further development after the Phase IIb results. Nocturia in BPH is believed to represent a potential market in excess of $1bn, and VA106483's potential in follow-on indications such as overactive bladder and general nocturia could add significant extra value.

The Phase I trial for VA111913 has recruited the last of its 99 volunteers, and is also expected to report data in H1 2009. Phase IIa trials are expected to start in the second half of this year, involving over 100 patients and completing in H2 2010. VA111913 is a vasopressin antagonist, with dysmenorrhoea (painful menstruation) believed to represent a multibillion dollar market for which there is currently no t
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Nektar Therapeutics (NASDAQ: ... today announced positive results from its Phase 3 ... extended half-life recombinant factor VIII (rFVIII) treatment for ... which met its primary endpoint in reducing annualized ... to the on-demand arm. Top-line results ...
(Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
(Date:8/21/2014)... percent of Americans believe the abuse of strong prescription pain ... safety issue in the United States , ... & Partners, a Cincinnati based research ... the prescription medication abuse problem and the need for medical ... facing our country," Rex Repass , CEO of the ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... 2011 ORTHOCON, Inc., a privately-held therapeutic device ... worldwide license agreement with Bezwada Biomedical to develop ... Bezwada Biomedical is an innovation-driven company ... biocompatible polyurethanes and polyamides derived from hydrolyzable isocyanates. ...
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... Spectrum CT , a breakthrough preclinical imaging system that ... and low dose microCT (micro computed tomography).  Spectrum CT ... with vital, unparalleled insights into complex biological systems in ...
Cached Medicine Technology:ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical 2Caliper Life Sciences Announces IVIS Spectrum CT 2Caliper Life Sciences Announces IVIS Spectrum CT 3
(Date:8/22/2014)... Reacting to naysayers who are being skeptical about the ... PRP therapy LA specialist has firmly stated that the ... practical well researched science and nothing to do with ... medical breakthrough technology which focuses on healing and repair ... , The Managing Director of one of the top ...
(Date:8/22/2014)... 22, 2014 Teen substance abuse has ... OH. Unfortunately, most young adults never receive the professional ... the community, the new Troubled Teens Columbus helpline was ... to overcome their drug and alcohol dependencies . ... teens and their parents can speak directly to a ...
(Date:8/22/2014)... 2014 Aid in Recovery, a full ... today regarding a recent bill introduced in ... a current legislator and retired police general. In House ... related offenders, rather than imprisonment. Aid in Recovery points ... solution for the drug addiction epidemic. , The bill, ...
(Date:8/21/2014)... August 22, 2014 Yoga Darshana Center, ... Island region, proudly announces the launch of their newest ... the West Babylon-based yoga studio’s new teacher training program, ... become teachers realize their dreams. , Since 2001, Yoga ... living in the surrounding area a place to learn ...
(Date:8/21/2014)... UWDress.com, a well-known wedding dress manufacturer, has added ... its online store. In addition to this, all these beautiful ... percent off) at the moment. The special offer will last ... kind online workers have updated its online category with these ... company’s website is a one stop place where worldwide people ...
Breaking Medicine News(10 mins):Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:Yoga Darshana Center Announces Launch of New Website LongIslandYogaTeacherTraining.com 2Health News:Beautiful Peacock Party Dresses for 2014 Offered by UWDress.com at the Moment 2
... and eventually eliminate cancer disparities among adults in the Philadelphia ... established the Center to Eliminate Cancer Disparities . ... oncologist at Thomas Jefferson University Hospital and Clinical ... Medical Oncology at Jefferson Medical College of Thomas Jefferson University, ...
... HealthDay Reporter , THURSDAY, Feb. 16 (HealthDay News) -- ... hidden source of arsenic, new research suggests. Researchers at ... syrup, is found in some infant formulas. Their report appears ... . Arsenic is a natural element that can contaminate ...
... program designed to support self-management and improve overall ... tested painACTION.com,s ability to increase the use of ... A total of 185 participants completed the study. ... they could prevent headaches and manage headache-related pain ...
... , WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers have discovered ... of cases of inherited dilated cardiomyopathy, a serious heart muscle ... In the study, published in the Feb. 16 issue ... analyzed the DNA of 312 people with dilated cardiomyopathy, 231 ...
... than half of women with rheumatoid arthritis (RA) and systemic ... choice has some influence on the smaller family size, findings ... journal of the American College of Rheumatology (ACR), suggest that ... number of offspring born to women with these chronic conditions. ...
... , WEDNESDAY, Feb. 15 (HealthDay News) -- The quit-smoking ... alcohol consumption, a small new study suggests. ... understood, but its use may increase blood pressure, heart ... the pleasurable effects of alcohol, the researchers said. ...
Cached Medicine News:Health News:Jefferson's Kimmel Cancer Center establishes Center to Eliminate Cancer Disparities 2Health News:Jefferson's Kimmel Cancer Center establishes Center to Eliminate Cancer Disparities 3Health News:Arsenic Might Be Found in Some Organic Foods: Study 2Health News:Arsenic Might Be Found in Some Organic Foods: Study 3Health News:painACTION.com improves migraine self-management and reduces migraine-related psychological distress 2Health News:Study Finds Gene Behind Inherited Cases of Enlarged Heart 2Health News:Study Finds Gene Behind Inherited Cases of Enlarged Heart 3Health News:Women with rheumatoid arthritis and lupus give birth to fewer children 2Health News:Stop-Smoking Drug May Also Curb Problem Drinking 2
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... for autoimmune testing feature single-well ANA screen ... specific reflex tests including dsDNA, and 6 ... SS-B (La), Scl-70 and Jo-1. In addition, ... line of products for Cardiolipins (IgA, IgG, ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: